<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:linked-data-default="http://data-service.theglobalfund.org/api" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <iati-identifier>47045-QMZ-T-PNT</iati-identifier>
  <reporting-org ref="47045" secondary-reporter="0" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">TB Supranational Reference Laboratory Network in Western and Central Africa</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Multicountry TB WC Africa NTP/SRL - Tuberculosis - National Tuberculosis Programme of the Republic of Benin - PNT.  This program has the following goals: To build Tuberculosis (TB) Supranational Reference Laboratory (SRL) Network strengthening the capacity of National TB Reference laboratories to improve TB and MDR-TB diagnosis in Western and Central Africa. The objectives of this program are: To establish a regional National Tuberculosis Reference Laboratories (NTRLs) network in the West and Central African Region.  To support regional NTRL network with a centre-of-excellence for quality trainings, technical assistance and management systems.  To build technical capacity of prioritized NTRLs in national level disease monitoring surveys.  To strengthen the technical and administrative capacity of Supranational TB Reference Laboratory (SRL), Cotonou, Benin</narrative>
  </description>
  <participating-org role="3">
   <narrative xml:lang="EN">National Tuberculosis Programme of the Republic of Benin</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">National Tuberculosis Programme of the Republic of Benin</narrative>
  </participating-org>
  <participating-org ref="47045" role="1" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </participating-org>
  <other-identifier ref="5f21d574-28ae-4b64-99d9-92298a68b01f" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <other-identifier ref="QMZ-T-PNT" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2018-07-27" type="1"></activity-date>
  <activity-date iso-date="2018-07-27" type="2"></activity-date>
  <activity-date iso-date="2024-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="4">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Wilfried THALMAS</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>wilfried.thalmas@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="3">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Wilfried THALMAS</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>wilfried.thalmas@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="3"></activity-scope>
  <recipient-region code="QPA" percentage="100" vocabulary="99" vocabulary-uri="https://data-service.theglobalfund.org/v2.1/odata/geographicareas">
   <narrative xml:lang="EN">Multicountry TB WC Africa NTP/SRL</narrative>
  </recipient-region>
  <sector code="12263" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Tuberculosis</narrative>
  </sector>
  <country-budget-items vocabulary="4">
   <budget-item code="C7B597A0-B5A0-4104-8A99-BA94F1C26180" percentage="14.93" vocabulary="4">
    <description>
     <narrative xml:lang="EN">External Professional services (EPS)</narrative>
    </description>
   </budget-item>
   <budget-item code="1BDFF48D-DF9D-43D5-BCDF-56FECE799046" percentage="5.81" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Equipment (HPE)</narrative>
    </description>
   </budget-item>
   <budget-item code="B035C5CE-BA09-412B-B386-BB992AA6A20F" percentage="2.39" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Non-Pharmaceuticals (HPNP)</narrative>
    </description>
   </budget-item>
   <budget-item code="AEEC85E4-0556-495F-8F31-584DD9FF4EF3" percentage="15.24" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Human Resources (HR)</narrative>
    </description>
   </budget-item>
   <budget-item code="400CEE75-C251-4A85-AA43-BD93DF71A408" percentage="1.5" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Indirect and Overhead Costs</narrative>
    </description>
   </budget-item>
   <budget-item code="FDEDB289-7073-424F-8780-856D2FB8F704" percentage="12.65" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Infrastructure (INF)</narrative>
    </description>
   </budget-item>
   <budget-item code="8FF157DA-C279-44D8-8148-6161B33C9E92" percentage="6.24" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Non-health equipment (NHP)</narrative>
    </description>
   </budget-item>
   <budget-item code="2F782C08-F342-42A0-ABA7-BD8E9C920F54" percentage="1.15" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Payment for Results</narrative>
    </description>
   </budget-item>
   <budget-item code="DC588E6C-6B65-46A8-90D7-3ACCD004E54D" percentage="2.03" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Procurement and Supply-Chain Management costs (PSM)</narrative>
    </description>
   </budget-item>
   <budget-item code="F4B643AF-C501-4424-B4BD-74AA0DA9F006" percentage="38.07" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Travel related costs (TRC)</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-03-31"></period-end>
   <value currency="USD" value-date="2019-01-01">209476</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2019-04-01"></period-start>
   <period-end iso-date="2019-06-30"></period-end>
   <value currency="USD" value-date="2019-01-01">359341</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2019-07-01"></period-start>
   <period-end iso-date="2019-09-30"></period-end>
   <value currency="USD" value-date="2019-01-01">81998</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2019-10-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2019-01-01">50266</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-03-31"></period-end>
   <value currency="USD" value-date="2019-01-01">191219</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-04-01"></period-start>
   <period-end iso-date="2020-06-30"></period-end>
   <value currency="USD" value-date="2019-01-01">148156</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-07-01"></period-start>
   <period-end iso-date="2020-09-30"></period-end>
   <value currency="USD" value-date="2019-01-01">1401133</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-10-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2019-01-01">1132020</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-03-31"></period-end>
   <value currency="USD" value-date="2019-01-01">133100</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-04-01"></period-start>
   <period-end iso-date="2021-06-30"></period-end>
   <value currency="USD" value-date="2019-01-01">636417</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-07-01"></period-start>
   <period-end iso-date="2021-09-30"></period-end>
   <value currency="USD" value-date="2019-01-01">577572</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-10-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2019-01-01">1076336</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-03-31"></period-end>
   <value currency="USD" value-date="2022-01-01">281866</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-04-01"></period-start>
   <period-end iso-date="2022-06-30"></period-end>
   <value currency="USD" value-date="2022-01-01">1084974</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-07-01"></period-start>
   <period-end iso-date="2022-09-30"></period-end>
   <value currency="USD" value-date="2022-01-01">608959</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-10-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-01-01">509029</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-01-01"></period-start>
   <period-end iso-date="2023-03-31"></period-end>
   <value currency="USD" value-date="2022-01-01">305849</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-04-01"></period-start>
   <period-end iso-date="2023-06-30"></period-end>
   <value currency="USD" value-date="2022-01-01">494244</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-07-01"></period-start>
   <period-end iso-date="2023-09-30"></period-end>
   <value currency="USD" value-date="2022-01-01">544890</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-10-01"></period-start>
   <period-end iso-date="2023-12-31"></period-end>
   <value currency="USD" value-date="2022-01-01">327367</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2024-01-01"></period-start>
   <period-end iso-date="2024-03-31"></period-end>
   <value currency="USD" value-date="2022-01-01">258546</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2024-04-01"></period-start>
   <period-end iso-date="2024-06-30"></period-end>
   <value currency="USD" value-date="2022-01-01">566213</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2024-07-01"></period-start>
   <period-end iso-date="2024-09-30"></period-end>
   <value currency="USD" value-date="2022-01-01">431242</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2024-10-01"></period-start>
   <period-end iso-date="2024-12-31"></period-end>
   <value currency="USD" value-date="2022-01-01">336828</value>
  </budget>
  <capital-spend percentage="5.81"></capital-spend>
  <transaction ref="10bcb2b7-75c3-4445-b763-e705be319b06">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-21"></transaction-date>
   <value currency="USD" value-date="2019-01-21">2646454.75</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="4707ce35-275e-42d7-b9cd-00d4ec462964">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-09-17"></transaction-date>
   <value currency="USD" value-date="2019-09-17">92210.61</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="c0048473-1576-496f-9cc2-29ae3ed9d329">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-08-05"></transaction-date>
   <value currency="USD" value-date="2020-08-05">719079.1</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="98c95ce7-c001-43c2-a1e2-399265a03d28">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-08-06"></transaction-date>
   <value currency="USD" value-date="2021-08-06">68449.25</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="33583186-5fbf-454f-920c-963789d05221">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-08-26"></transaction-date>
   <value currency="USD" value-date="2021-08-26">-394841.33</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="c574548d-d515-4c17-b975-6201b9491633">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-08-26"></transaction-date>
   <value currency="USD" value-date="2021-08-26">893582.08</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="3b2acf75-1368-47c3-8258-d291120e56f0">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-10-12"></transaction-date>
   <value currency="USD" value-date="2021-10-12">-10131.6</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="7c4bf983-3679-475e-b34b-4f56f8640d5c">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-12-13"></transaction-date>
   <value currency="USD" value-date="2021-12-13">272548.49</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="11be4dff-3324-4f2c-80f9-9c76b60c143c">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-31"></transaction-date>
   <value currency="USD" value-date="2022-01-31">6544.59</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="9d56152e-9d98-4dfd-8d1e-0eda1e6cef7b">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-02-02"></transaction-date>
   <value currency="USD" value-date="2022-02-02">3284916.79</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="373b9562-0113-49c6-bd45-4dae29a4fa2d">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-06-02"></transaction-date>
   <value currency="USD" value-date="2022-06-02">-1568.4</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="2a134f39-71e3-4a01-83e6-477741b0b595">
   <transaction-type code="7"></transaction-type>
   <transaction-date iso-date="2021-10-01"></transaction-date>
   <value currency="USD" value-date="2021-10-01">-10131.6</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QMZ-T-PNT.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="4cc15169-2142-42e5-8771-e6edf8e93099">
   <transaction-type code="7"></transaction-type>
   <transaction-date iso-date="2022-06-01"></transaction-date>
   <value currency="USD" value-date="2022-06-01">-1568.4</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QMZ-T-PNT.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="a5e19364-0194-4b0a-b49e-f080765a2e37">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-01-22"></transaction-date>
   <value currency="USD" value-date="2019-01-22">373947.88</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="71e93703-91a0-4b3c-8749-6fa380459145">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-18"></transaction-date>
   <value currency="USD" value-date="2019-07-18">252816.96</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="726e7cb9-2b2a-428b-842e-0346b8a910d5">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-10-10"></transaction-date>
   <value currency="USD" value-date="2019-10-10">155020.26</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="8dc2bf5d-977b-4599-accb-ec10ccea2d06">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-05"></transaction-date>
   <value currency="USD" value-date="2019-12-05">23936.7</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="cb68f9d6-78e5-43a8-8f1b-fa1260280504">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-24"></transaction-date>
   <value currency="USD" value-date="2020-01-24">30791.87</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="565f71af-d2db-40c4-94ab-7e2249dbacec">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-20"></transaction-date>
   <value currency="USD" value-date="2020-03-20">1445891.59</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="9b6af23b-d339-4092-899a-70c4aa10ffb2">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-27"></transaction-date>
   <value currency="USD" value-date="2020-03-27">61418.74</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="a4becb6c-6abd-444a-9008-1dba5b345b62">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-17"></transaction-date>
   <value currency="USD" value-date="2020-09-17">159030.07</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="a68f581b-e4ff-4135-b97c-67f175be2e53">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-12"></transaction-date>
   <value currency="USD" value-date="2021-03-12">477090.24</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="8c24700b-1bf2-4d76-8191-14402320b43b">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-19"></transaction-date>
   <value currency="USD" value-date="2021-04-19">82958.78</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="80a9524b-dbfd-4493-852c-254f2f6c5516">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-02"></transaction-date>
   <value currency="USD" value-date="2021-09-02">893582.08</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="91db553a-1368-4d1e-b5be-e115041cf606">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-08"></transaction-date>
   <value currency="USD" value-date="2021-09-08">68449.25</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="cb6d9677-13f9-4825-af47-afaa1a33f604">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-16"></transaction-date>
   <value currency="USD" value-date="2021-12-16">266011.67</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="06f7d30b-73b7-4b18-bf41-c278df8a43c8">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-16"></transaction-date>
   <value currency="USD" value-date="2021-12-16">6536.81</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="c6f9dec5-e88b-49c6-bd21-58e8f531c64b">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-02-03"></transaction-date>
   <value currency="USD" value-date="2022-02-03">6544.59</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="41a75d70-c62c-4a21-a652-199beff8a25f">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-02-10"></transaction-date>
   <value currency="USD" value-date="2022-02-10">276643.68</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="033afe1f-ff9d-4cdf-8578-6ef9aba8d5c2">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-02-10"></transaction-date>
   <value currency="USD" value-date="2022-02-10">376150.66</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QMZ-T-PNT.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Coverage / Output indicator for QMZ-T-PNT</narrative>
   </title>
   <indicator aggregation-status="0" measure="2">
    <title>
     <narrative xml:lang="EN">MDR-TB-other2: Number and percent of NTRLs able to provide 2nd line quality assured DST</narrative>
    </title>
    <baseline value="5.88" year="2017">
     <comment>
      <narrative xml:lang="EN">Numerator: 1 Denominator: 17 Percentage: 5.88</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target value="58.80">
      <comment>
       <narrative xml:lang="EN">Numerator: 10 Denominator: 17 Percentage: 58.80</narrative>
      </comment>
     </target>
     <actual value="66.70">
      <comment>
       <narrative xml:lang="EN">Numerator: 10 Denominator: 15 Percentage: 66.70</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2019-01-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target value="50.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 6 Denominator: 12 Percentage: 50.00</narrative>
      </comment>
     </target>
     <actual value="33.30">
      <comment>
       <narrative xml:lang="EN">Numerator: 4 Denominator: 12 Percentage: 33.30</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target value="70.60">
      <comment>
       <narrative xml:lang="EN">Numerator: 12 Denominator: 17 Percentage: 70.60</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="2">
    <title>
     <narrative xml:lang="EN">MDR-TB-other2: Number and percentage of NTRLs showing adequate performance for (genotypic) susceptibility testing for second-line anti-tuberculosis drugs</narrative>
    </title>
    <baseline value="66.67" year="2020">
     <comment>
      <narrative xml:lang="EN">Numerator: 10 Denominator: 15 Percentage: 66.67</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="70.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 11.2 Denominator: 16 Percentage: 70.00</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target value="71.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 12.07 Denominator: 17 Percentage: 71.00</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2024-01-01"></period-start>
     <period-end iso-date="2024-12-31"></period-end>
     <target value="72.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 12.96 Denominator: 18 Percentage: 72.00</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="2">
    <title>
     <narrative xml:lang="EN">TCP-Other1: Percentage of NTRLs with adequate external quality assurance performance for smear microscopy among the total number of NTRLs performing smear microscopy during the period</narrative>
    </title>
    <baseline value="66.67" year="2020">
     <comment>
      <narrative xml:lang="EN">Numerator: 16 Denominator: 24 Percentage: 66.67</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="75.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 18 Denominator: 24 Percentage: 75.00</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target value="79.20">
      <comment>
       <narrative xml:lang="EN">Numerator: 19 Denominator: 24 Percentage: 79.20</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2024-01-01"></period-start>
     <period-end iso-date="2024-12-31"></period-end>
     <target value="83.30">
      <comment>
       <narrative xml:lang="EN">Numerator: 20 Denominator: 24 Percentage: 83.30</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="2">
    <title>
     <narrative xml:lang="EN">MDR-TB-other3: Number and percentage of sensibility tests performed by SRL as a direct service to NTRLs</narrative>
    </title>
    <baseline value="52.22" year="2020">
     <comment>
      <narrative xml:lang="EN">Numerator: 188 Denominator: 360 Percentage: 52.22</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="65.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 245.7 Denominator: 378 Percentage: 65.00</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target value="70.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 264.6 Denominator: 378 Percentage: 70.00</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2024-01-01"></period-start>
     <period-end iso-date="2024-12-31"></period-end>
     <target value="75.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 283.5 Denominator: 378 Percentage: 75.00</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="2">
    <title>
     <narrative xml:lang="EN">Percentage of DST laboratories showing adequate performance on External Quality Assurance</narrative>
    </title>
    <baseline value="11.76" year="2017">
     <comment>
      <narrative xml:lang="EN">Numerator: 2 Denominator: 17 Percentage: 11.76</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target value="41.20">
      <comment>
       <narrative xml:lang="EN">Numerator: 7 Denominator: 17 Percentage: 41.20</narrative>
      </comment>
     </target>
     <actual value="60.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 9 Denominator: 15 Percentage: 60.00</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2019-01-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target value="25.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 3 Denominator: 12 Percentage: 25.00</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target value="58.80">
      <comment>
       <narrative xml:lang="EN">Numerator: 10 Denominator: 17 Percentage: 58.80</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="2">
    <title>
     <narrative xml:lang="EN">TCP-Other2: Number and percentage of stars obtained by all NTRLs that participated in the SLIPTA-WHO QMS assessment</narrative>
    </title>
    <baseline value="23.81" year="2020">
     <comment>
      <narrative xml:lang="EN">Numerator: 25 Denominator: 105 Percentage: 23.81</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="27.50">
      <comment>
       <narrative xml:lang="EN">Numerator: 33 Denominator: 120 Percentage: 27.50</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target value="30.80">
      <comment>
       <narrative xml:lang="EN">Numerator: 37 Denominator: 120 Percentage: 30.80</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2024-01-01"></period-start>
     <period-end iso-date="2024-12-31"></period-end>
     <target value="34.20">
      <comment>
       <narrative xml:lang="EN">Numerator: 41 Denominator: 120 Percentage: 34.20</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="2">
    <title>
     <narrative xml:lang="EN">MDR-TB-other1 : Number and percentage of NTRLs showing adequate performance for (phenotypic) susceptibility testing for 2nd line anti-tuberculosis drugs</narrative>
    </title>
    <baseline value="33.33" year="2020">
     <comment>
      <narrative xml:lang="EN">Numerator: 3 Denominator: 9 Percentage: 33.33</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="54.50">
      <comment>
       <narrative xml:lang="EN">Numerator: 6 Denominator: 11 Percentage: 54.50</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target value="58.30">
      <comment>
       <narrative xml:lang="EN">Numerator: 7 Denominator: 12 Percentage: 58.30</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2024-01-01"></period-start>
     <period-end iso-date="2024-12-31"></period-end>
     <target value="66.70">
      <comment>
       <narrative xml:lang="EN">Numerator: 8 Denominator: 12 Percentage: 66.70</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="2">
    <title>
     <narrative xml:lang="EN">MDR-TB-other1: Number and percent of NTRLs able to provide 1st line Quality assured DST (phenotypic)</narrative>
    </title>
    <baseline value="23.53" year="2017">
     <comment>
      <narrative xml:lang="EN">Numerator: 4 Denominator: 17 Percentage: 23.53</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target value="58.80">
      <comment>
       <narrative xml:lang="EN">Numerator: 10 Denominator: 17 Percentage: 58.80</narrative>
      </comment>
     </target>
     <actual value="44.40">
      <comment>
       <narrative xml:lang="EN">Numerator: 4 Denominator: 9 Percentage: 44.40</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2019-01-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target value="50.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 6 Denominator: 12 Percentage: 50.00</narrative>
      </comment>
     </target>
     <actual value="41.70">
      <comment>
       <narrative xml:lang="EN">Numerator: 5 Denominator: 12 Percentage: 41.70</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target value="70.60">
      <comment>
       <narrative xml:lang="EN">Numerator: 12 Denominator: 17 Percentage: 70.60</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="2">
    <title>
     <narrative xml:lang="EN">TCP-other1: Percentage of NTRLs showing adequate performance in external quality assurance for smear microscopy among the total number of NTRLs that undertake smear microscopy during the reporting period</narrative>
    </title>
    <baseline value="23.53" year="2017">
     <comment>
      <narrative xml:lang="EN">Numerator: 4 Denominator: 17 Percentage: 23.53</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target value="70.60">
      <comment>
       <narrative xml:lang="EN">Numerator: 12 Denominator: 17 Percentage: 70.60</narrative>
      </comment>
     </target>
     <actual value="76.20">
      <comment>
       <narrative xml:lang="EN">Numerator: 16 Denominator: 21 Percentage: 76.20</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2019-01-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target value="50.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 6 Denominator: 12 Percentage: 50.00</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target value="88.20">
      <comment>
       <narrative xml:lang="EN">Numerator: 15 Denominator: 17 Percentage: 88.20</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="2">
    <title>
     <narrative xml:lang="EN">MDR-TB-other3: Number and percent of DST test carried out by SRL as direct service to NTRLs</narrative>
    </title>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target value="66.70">
      <comment>
       <narrative xml:lang="EN">Numerator: 400 Denominator: 600 Percentage: 66.70</narrative>
      </comment>
     </target>
     <actual value="52.20">
      <comment>
       <narrative xml:lang="EN">Numerator: 188 Denominator: 360 Percentage: 52.20</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2019-01-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target value="16.70">
      <comment>
       <narrative xml:lang="EN">Numerator: 100 Denominator: 600 Percentage: 16.70</narrative>
      </comment>
     </target>
     <actual value="23.50">
      <comment>
       <narrative xml:lang="EN">Numerator: 39 Denominator: 166 Percentage: 23.50</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target value="100.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 600 Denominator: 600 Percentage: 100.00</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="1">
    <title>
     <narrative xml:lang="EN">TCP-other2: Number and % of NTRLs that were assessed for Lab QMS WHO-SLIPTA and achieved at least one star more grading</narrative>
    </title>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target value="5">
      <comment>
       <narrative xml:lang="EN">Numerator: 5 Denominator: 17 Percentage: 29.40</narrative>
      </comment>
     </target>
     <actual value="10">
      <comment>
       <narrative xml:lang="EN">Numerator: 10 Denominator: 21 Percentage: 47.60</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target value="10">
      <comment>
       <narrative xml:lang="EN">Numerator: 10 Denominator: 17 Percentage: 58.80</narrative>
      </comment>
     </target>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
